Missed Signals: The Economic Implications of Current Health Technology Assessment Protocols for Diagnostics

Speaker(s)

Moderator: Ricardo De La Fuente, PharmD, PhD, MBA, Market Access, GE Healthcare, Hampton, NH, USA
Speakers: Alistair McGuire, BA, MLitt, PhD, London School of Economics, London, UK; Alexander Natz, LLM, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Brussels, Belgium; Laura Sampietro-Colom, MD, PhD, Hospital Clínic Barcelona, Barcelona, Spain; Montserrat Chivite, MS, GE HealthCare, Madrid, Spain

Presentation Documents

Health Technology Assessment (HTA) plays a crucial role in evaluating the benefits of medical technologies and determining their value in the healthcare ecosystem. From diagnostics to therapeutics, HTA systematically assesses value attributes and supporting evidence. However, assessing diagnostic technologies presents unique challenges due to their limited direct impact on health outcomes.

This educational symposium aims to delve into the methodologies, processes, and results related to HTA assessment specifically for diagnostic imaging technologies. We will review the results from research and explore whether existing methodologies adequately capture the full value of these diagnostic technologies.

After the presentation, a panel with stakeholders representing different perspectives will engage in a debate to discuss the benefits and drawbacks of different HTA approaches for diagnostics to identify the suitability of current frameworks and areas for improvement.

Join us as we explore the intersection of HTA, evidence, and healthcare outcomes in the context of diagnostic imaging.

Sponsor: GE HealthCare

Code

217

Topic

Health Technology Assessment